Potential benefits of JAK inhibitor therapy in Blau syndrome: a case report.

Abstract excerpt

Blau syndrome is a rare autoinflammatory disorder caused by gain-of-function mutations in the NOD2 (nucleotide binding oligomerization domain containing 2 receptor) gene. Blau Syndrome presents with the diagnostic triad of chronic polyarticular synovitis, recurrent uveitis, and dermatitis. Notably, patients often develop systemic granulomatous inflammation affecting multiple organs, particularly the kidney and...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Arthritis
• Share to Azetidines
• Share to Hereditary Autoinflammatory Diseases